On ECHEMI
Home > Drugs > Coxsackievirus B infection in newborns
Coxsackievirus B infection in newborns
Coxsackie virus B (CVB) infection mainly affects newborns with low immunity and areas with poor sanitary conditions. Clinically, it is characterized by inflammation and damage to many organs such as the myocardium and brain. Severe outbreaks of this disease have a mortality rate of up to 26% to 69.4%, which is very harmful to newborns and has attracted the attention of neonatologists around the world. Since it was reported in Coxsackie Town, New York, USA in 1954, in addition to causing sporadic infections in newborns, it has successively occurred in some parts of the world. In recent years, epidemics of varying scales have also occurred in nurseries in Beijing, Huangshan, Shenyang and other regions of my country.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    Newborns
  • Related symptoms:

    Cyanosis pale complexion abdominal distension gastrointestinal symptoms fever
  • Concurrent disease:

Related Drugs
Meclofenoxate Hydrochloride Capsules
Indication: Traumatic coma, alcohol poisoning, neonatal hypoxia, and enuresis in children.
Manufacturer:

China Resources Zizhu Pharmaceutical Co., Ltd.

Jianer Xiaoshi Oral Liquid
Manufacturer:

Guangdong Litai Pharmaceutical Holdings Co., Ltd.

Related Ingredients
  • 2-(Dimethylamino)ethyl (4-chlorphenoxy)acetate list

    51-68-3
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.